Creative Planning
ACOR

Creative Planning’s Acorda Therapeutics ACOR Stock Holding History

Creative Planning’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1
Closed -$2K – 3951
2017
Q2 		$2K Hold
1
– – ﹤0.01% 4352
2017
Q1 		$2K Hold
1
– – ﹤0.01% 4346
2016
Q4 		$2K Hold
1
– – ﹤0.01% 4333
2016
Q3 		$2K Hold
1
– – ﹤0.01% 4281
2016
Q2 		$3K Sell
1
-7
-88% -$22.8K ﹤0.01% 3927
2016
Q1 		$26K Sell
8
-2
-20% -$8.3K ﹤0.01% 2585
2015
Q4 		$49K Buy
10
+9
+900% +$39.3K ﹤0.01% 2147
2015
Q3 		$4K Buy
+1
New +$3.88K ﹤0.01% 3747
2015
Q1 		– Sell
-38
Closed -$184K – 4458
2014
Q4 		$184K Buy
+38
New +$163K ﹤0.01% 1193

Other funds holding ACOR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Creative Planning's ACOR Position: Q3 2017 in Review

Creative Planning sold out of Acorda Therapeutics (ACOR) in Q3 2017, closing a stake of 1 share — an estimated $2K sold.

Creative Planning first reported a position in ACOR in Q4 2014 and held it in 9 quarters. The position peaked at $184K in Q4 2014. 152 funds tracked by Wall St. Rank hold ACOR as of Q3 2017.

  • Creative Planning reported no remaining Acorda Therapeutics position as of Q3 2017 after selling out during the quarter.
  • Creative Planning sold 1 Acorda Therapeutics share in Q3 2017, an estimated $2K.
  • Creative Planning first reported a position in Acorda Therapeutics in Q4 2014 and held it in 9 quarters.
  • Creative Planning's Acorda Therapeutics position peaked at $184K in Q4 2014.
  • 152 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q3 2017.

Based on Creative Planning's 13F filing for Q3 2017, filed 17 Oct 2017.